265 related articles for article (PubMed ID: 37615117)
1. The Multifunction Role of Tumor-Associated Mesenchymal Stem Cells and Their Interaction with Immune Cells in Breast Cancer.
Chauhan A; Agarwal S; Masih M; Gautam PK
Immunol Invest; 2023 Nov; 52(7):856-878. PubMed ID: 37615117
[TBL] [Abstract][Full Text] [Related]
2. Comparative immunomodulatory properties of mesenchymal stem cells derived from human breast tumor and normal breast adipose tissue.
Sineh Sepehr K; Razavi A; Hassan ZM; Fazel A; Abdollahpour-Alitappeh M; Mossahebi-Mohammadi M; Yekaninejad MS; Farhadihosseinabadi B; Hashemi SM
Cancer Immunol Immunother; 2020 Sep; 69(9):1841-1854. PubMed ID: 32350594
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stromal cells for bone sarcoma treatment: Roadmap to clinical practice.
Stamatopoulos A; Stamatopoulos T; Gamie Z; Kenanidis E; Ribeiro RDC; Rankin KS; Gerrand C; Dalgarno K; Tsiridis E
J Bone Oncol; 2019 Jun; 16():100231. PubMed ID: 30956944
[TBL] [Abstract][Full Text] [Related]
4. Differential response of mesenchymal stromal cells (MSCs) to type 1 ex vivo cytokine priming: implications for MSC therapy.
Burnham AJ; Foppiani EM; Goss KL; Jang-Milligan F; Kamalakar A; Bradley H; Goudy SL; Trochez CM; Dominici M; Daley-Bauer L; Gibson G; Horwitz EM
Cytotherapy; 2023 Dec; 25(12):1277-1284. PubMed ID: 37815775
[TBL] [Abstract][Full Text] [Related]
5. Carcinoma-Associated Mesenchymal Stem/Stromal Cells: Architects of the Pro-tumorigenic Tumor Microenvironment.
Frisbie L; Buckanovich RJ; Coffman L
Stem Cells; 2022 Aug; 40(8):705-715. PubMed ID: 35583414
[TBL] [Abstract][Full Text] [Related]
6. The Immunomodulatory Properties of the Human Amnion-Derived Mesenchymal Stromal/Stem Cells Are Induced by INF-γ Produced by Activated Lymphomonocytes and Are Mediated by Cell-To-Cell Contact and Soluble Factors.
Bulati M; Miceli V; Gallo A; Amico G; Carcione C; Pampalone M; Conaldi PG
Front Immunol; 2020; 11():54. PubMed ID: 32117234
[TBL] [Abstract][Full Text] [Related]
7. Cancer-associated mesenchymal stem/stromal cells: role in progression and potential targets for therapeutic approaches.
Hazrati A; Malekpour K; Mirsanei Z; Khosrojerdi A; Rahmani-Kukia N; Heidari N; Abbasi A; Soudi S
Front Immunol; 2023; 14():1280601. PubMed ID: 38022534
[TBL] [Abstract][Full Text] [Related]
8. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.
Yang M; Li J; Gu P; Fan X
Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371
[TBL] [Abstract][Full Text] [Related]
9. Preconditioning of murine mesenchymal stem cells synergistically enhanced immunomodulation and osteogenesis.
Lin T; Pajarinen J; Nabeshima A; Lu L; Nathan K; Jämsen E; Yao Z; Goodman SB
Stem Cell Res Ther; 2017 Dec; 8(1):277. PubMed ID: 29212557
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive properties of mesenchymal stem cells: advances and applications.
De Miguel MP; Fuentes-Julián S; Blázquez-Martínez A; Pascual CY; Aller MA; Arias J; Arnalich-Montiel F
Curr Mol Med; 2012 Jun; 12(5):574-91. PubMed ID: 22515979
[TBL] [Abstract][Full Text] [Related]
11. Human mesenchymal stromal/stem cells acquire immunostimulatory capacity upon cross-talk with natural killer cells and might improve the NK cell function of immunocompromised patients.
Cui R; Rekasi H; Hepner-Schefczyk M; Fessmann K; Petri RM; Bruderek K; Brandau S; Jäger M; Flohé SB
Stem Cell Res Ther; 2016 Jul; 7(1):88. PubMed ID: 27388156
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway.
Katanov C; Lerrer S; Liubomirski Y; Leider-Trejo L; Meshel T; Bar J; Feniger-Barish R; Kamer I; Soria-Artzi G; Kahani H; Banerjee D; Ben-Baruch A
Stem Cell Res Ther; 2015 May; 6(1):87. PubMed ID: 25928089
[TBL] [Abstract][Full Text] [Related]
13. Potential surrogate quantitative immunomodulatory potency assay for monitoring human umbilical cord-derived mesenchymal stem cells production.
Teng SW; Sung HY; Wen YC; Chen SY; Lovel R; Chang WY; Wu TB; Hsuan YC; Lin W
Cell Biol Int; 2021 May; 45(5):1072-1081. PubMed ID: 33470478
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory licensed equine MSCs are chondroprotective and exhibit enhanced immunomodulation in an inflammatory environment.
Cassano JM; Schnabel LV; Goodale MB; Fortier LA
Stem Cell Res Ther; 2018 Apr; 9(1):82. PubMed ID: 29615127
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cell secretome and regenerative therapy after cancer.
Zimmerlin L; Park TS; Zambidis ET; Donnenberg VS; Donnenberg AD
Biochimie; 2013 Dec; 95(12):2235-45. PubMed ID: 23747841
[TBL] [Abstract][Full Text] [Related]
16. CXCR4/TGF-β1 mediated self-differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and promoted colorectal carcinoma development.
Tan HX; Xiao ZG; Huang T; Fang ZX; Liu Y; Huang ZC
Cancer Biol Ther; 2020; 21(3):248-257. PubMed ID: 31818187
[No Abstract] [Full Text] [Related]
17. Mesenchymal Stromal Cells Induce Peculiar Alternatively Activated Macrophages Capable of Dampening Both Innate and Adaptive Immune Responses.
Chiossone L; Conte R; Spaggiari GM; Serra M; Romei C; Bellora F; Becchetti F; Andaloro A; Moretta L; Bottino C
Stem Cells; 2016 Jul; 34(7):1909-21. PubMed ID: 27015881
[TBL] [Abstract][Full Text] [Related]
18. Tumor cells educate mesenchymal stromal cells to release chemoprotective and immunomodulatory factors.
Le Naour A; Prat M; Thibault B; Mével R; Lemaitre L; Leray H; Joubert MV; Coulson K; Golzio M; Lefevre L; Mery E; Martinez A; Ferron G; Delord JP; Coste A; Couderc B
J Mol Cell Biol; 2020 Apr; 12(3):202-215. PubMed ID: 31504643
[TBL] [Abstract][Full Text] [Related]
19. Encapsulated human mesenchymal stem cells (eMSCs) as a novel anti-cancer agent targeting breast cancer stem cells: Development of 3D primed therapeutic MSCs.
Mandal S; Arfuso F; Sethi G; Dharmarajan A; Warrier S
Int J Biochem Cell Biol; 2019 May; 110():59-69. PubMed ID: 30735730
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulatory Effect of Human Umbilical Cord Blood-derived Mesenchymal Stem Cells on Activated T-lymphocyte.
Lotfinejad P; Shamsasenjan K; Baradaran B; Safarzadeh E; Kazemi T; Movassaghpour AA
Iran J Allergy Asthma Immunol; 2021 Dec; 20(6):711-720. PubMed ID: 34920654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
